Detection and identification of designer drugs by nanoparticle-based NMR chemosensing. Issue 21 (9th May 2018)

• Record Type: Journal Article
• Authors: Gabrielli, Luca; Rosa-Gastaldo, Daniele; Salvia, Marie-Virginie; Springhetti, Sara; Rastrelli, Federico; Mancin, Fabrizio
• Is Part Of: Chemical science. Volume 9:Issue 21(2018)
• Page Start: 4777
• Page End: 4784
• Publication Date: 2018-05-09
• Subjects: Chemistry -- Periodicals; 540.5
• DOI: 10.1039/c8sc01283k
• Languages: English
• ISSNs: 2041-6520

Abstract

Abstract : Unknown designer drugs can be recognized by self-organized nanoparticle receptors and identified by magnetization transfer NMR. Abstract : Properly designed monolayer-protected nanoparticles (2 nm core diameter) can be used as nanoreceptors for selective detection and identification of phenethylamine derivatives (designer drugs) in water. The molecular recognition mechanism is driven by the combination of electrostatic and hydrophobic interactions within the coating monolayer. Each nanoparticle can bind up to 30–40 analyte molecules. The affinity constants range from 10 5 to 10 6 M −1 and are modulated by the hydrophobicity of the aromatic moiety in the substrate. Detection of drug candidates (such as amphetamines and methamphetamines) is performed by using magnetization (NOE) or saturation (STD) transfer NMR experiments. In this way, the NMR spectrum of the drug is isolated from that of the mixture, allowing broad-class multianalyte detection and even identification of unknowns. The introduction of a dimethylsilane moiety in the coating monolayer allows performing STD experiments in complex mixtures. In this way, a detection limit of 30 μM is reached with standard instruments.